C urrently, Ozempic is only approved to treat type 2 diabetes. But in recent years, the semaglutide injection has become a ...

A new study suggests that semaglutide, a drug commonly used to treat diabetes, may help protect the brain from the effects of ...

He and his team then compared the diagnoses for hair loss in these patients’ medical records and found that those prescribed ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

People who can't afford the name-brand drugs have been flocking to compounded versions, which are available at a fraction of ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

The use of GLP-1 receptor agonists, like semaglutide, to treat type 2 diabetes is not associated with an increased risk of ...

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

Semaglutide and tirzepatide were the least cost-effective of four obesity drugs examined in a microsimulation model. A multifaceted approach is needed to reduce financial barriers to obesity ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...